Table 2. Demographic, clinical features and laboratory assessments of disease control patients with jSSc at study time (n=19).
| Demographic characteristics | |
| Mean age (mean±SD) (years) | 17.47±2.39 years |
| Female/male ratio (%, n) | 8.5/1 (17 female/2 male) |
| Mean disease duration (years) (range) | 6.89±3.54 years (range 1.0–18.0 years) |
| Mean disease onset (years) (range) | 10.42±3.31 years (range 2.0–17.0 years) |
| Clinical features, n (%) | |
| Sclerosis and induration | 19 (100%) |
| Sclerodactyly | 19 (100%) |
| Raynaud’s syndrome | 14 (73.7%) |
| Telangiectasias | 13 (68.4%) |
| Pulmonary hypertension | 3 (15.8%) |
| Arthalgia | 14 (73.7%) |
| Arthritis | 6 (31.6%) |
| Dysphagia | 5 (26.3%) |
| Ocular involvement | 9 (47.4%) |
| Disease activity | |
| The mean J4S | 6.62±4.84 |
| Laboratory assessments | |
| Anti Scl-70 (IU/mL) | 56.56±92.12 |
| Hgb (g/dL) | 12.45±1.31 |
jSScjuvenile systemic sclerosis